Antonio Capaldi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 4
- CAR-T cell therapy research 3
- Peptidase Inhibition and Analysis 3
-
- Hematopoietic Stem Cell Transplantation 3
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Massimo Aglietta (14 shared papers)Giovannino Ciccone (3 shared papers)Mario Boccadoro (4 shared papers)Vincenzo Callea (2 shared papers)Antonio Palumbo (2 shared papers)Pellegrino Musto (2 shared papers)L. Lombardo (1 shared paper)Renato Zambello (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (3 papers)International Immunology (1 paper)British Journal of Haematology (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Antonio Capaldi
19 papers receiving 657 citations
Peers
Comparison fields: 5 of 59
- Hematology 324
- Oncology 333
- Immunology 112
- Molecular Biology 231
- Hepatology 20
Countries citing papers authored by Antonio Capaldi
This map shows the geographic impact of Antonio Capaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Capaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Capaldi more than expected).
Fields of papers citing papers by Antonio Capaldi
This network shows the impact of papers produced by Antonio Capaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Capaldi. The network helps show where Antonio Capaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Capaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 262 | |
| 2 | 2008 | 101 | |
| 3 | 1995 | 51 | |
| 4 | 2011 | 48 | |
| 5 | 2011 | 37 | |
| 6 | 2004 | 36 | |
| 7 | 2003 | 35 | |
| 8 | 2009 | 22 | |
| 9 | 2001 | 21 | |
| 10 | 2003 | 20 | |
| 11 | Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients. | 2000 | 15 |
| 12 | 2011 | 12 | |
| 13 | 2003 | 8 | |
| 14 | 2005 | 5 | |
| 15 | 1982 | 3 | |
| 16 | 2005 | 3 | |
| 17 | 2007 | 2 | |
| 18 | 2006 | 2 | |
| 19 | 2003 | 2 | |
| 20 | 2005 | 0 |
About Antonio Capaldi
Antonio Capaldi is a scholar working on Oncology, Hematology, Immunology, Genetics and Molecular Biology, having authored 21 papers that have together received 685 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (324 citations), Oncology (333 citations), Immunology (112 citations), Molecular Biology (231 citations) and Hepatology (20 citations). Antonio Capaldi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Massimo Aglietta, Giovannino Ciccone, Mario Boccadoro, Vincenzo Callea, Antonio Palumbo, Pellegrino Musto, L. Lombardo, Renato Zambello, Michèle Cavo and Marco Montanaro. Their work appears in journals such as Blood, Journal of Clinical Oncology, International Immunology, British Journal of Haematology and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.